Ngā hua rapu - Peter D. Arkwright
- E whakaatu ana i te 1 - 20 hua o te 78
- Haere ki te Whārangi Whai Ake
-
1
-
2
Impact of a Decade of Research Into Atopic Dermatitis mā Peter D. Arkwright, Jennifer J. Koplin
I whakaputaina 2022Revisão -
3
Autoimmunity in human primary immunodeficiency diseases mā Peter D. Arkwright, Mario Abinun, Andrew J. Cant
I whakaputaina 2002Revisão -
4
Mast cell disorders: From infancy to maturity mā Amy Wilcock, Rajia Bahri, Silvia Bulfone‐Paus, Peter D. Arkwright
I whakaputaina 2018Revisão -
5
-
6
Pre-eclampsia is associated with an increase in trophoblast glycogen content and glycogen synthase activity, similar to that found in hydatidiform moles. mā Peter D. Arkwright, T. W. Rademacher, Raymond A. Dwek, Christopher W.G. Redman
I whakaputaina 1993Artigo -
7
-
8
-
9
Real-world outcomes of children treated with dupilumab for moderate-to-severe atopic dermatitis: a single-centre retrospective observational UK study mā Mozhgan Hosseini-Ashrafi, Tim H Clayton, Michelle Herring, Nichola Herety, Peter D. Arkwright
I whakaputaina 2024Artigo -
10
-
11
-
12
-
13
C1q Deficiency Leads to the Defective Suppression of IFN-α in Response to Nucleoprotein Containing Immune Complexes mā Deanna M. Santer, Brian E. Hall, Thaddeus C. George, Stephanie Tangsombatvisit, Chih Long Liu, Peter D. Arkwright, Keith B. Elkon
I whakaputaina 2010Artigo -
14
-
15
Human Complete Stat-1 Deficiency Is Associated with Defective Type I and II IFN Responses In Vitro but Immunity to Some Low Virulence Viruses In Vivo mā Ariane Chapgier, Robert Wynn, Emmanuelle Jouanguy, Orchidée Filipe‐Santos, Shen‐Ying Zhang, Jacqueline Feinberg, Kay C. Hawkins, Jean‐Laurent Casanova, Peter D. Arkwright
I whakaputaina 2006Artigo -
16
14 Years after Discovery: Clinical Follow-up on 15 Patients with Inducible Co-Stimulator Deficiency mā Johanna Schepp, Janet Chou, Andrea Skrabl‐Baumgartner, Peter D. Arkwright, Karin R. Engelhardt, Sophie Hambleton, Tomohiro Morio, E Röther, Klaus Warnatz, Raif S. Geha, Bodo Grimbacher
I whakaputaina 2017Artigo -
17
Infections in Children Aged 6 Months to 5 Years Treated with Dupilumab in a Placebo-Controlled Clinical Trial of Moderate-to-Severe Atopic Dermatitis mā Amy S. Paller, Elaine C. Siegfried, Michael J. Cork, Peter D. Arkwright, Lawrence F. Eichenfield, Michele Ramien, Faisal A. Khokhar, Zhen Chen, Annie Zhang, Sonya Cyr
I whakaputaina 2024Artigo -
18
Fas stimulation of T lymphocytes promotes rapid intercellular exchange of death signals via membrane nanotubes mā Peter D. Arkwright, Francesca Luchetti, Julien Tour, Charlotte F. Roberts, Rahna Ayub, Ana Paula Morales, José J. Rodrı́guez, Andrew Gilmore, Barbara Canonico, Stefano Papa, Mauro Degli Esposti
I whakaputaina 2009Artigo -
19
Type 2 immunity in the skin and lungs mā Cezmi A. Akdiş, Peter D. Arkwright, Marie‐Charlotte Brüggen, William W. Busse, Massimo Gadina, Emma Guttman‐Yassky, Kenji Kabashima, Yasutaka Mitamura, Laura Vian, Jianni Wu, Óscar Palomares
I whakaputaina 2020Revisão -
20
Impaired Epstein-Barr virus–specific CD8+ T-cell function in X-linked lymphoproliferative disease is restricted to SLAM family–positive B-cell targets mā Andrew D. Hislop, Umaimainthan Palendira, Alison M. Leese, Peter D. Arkwright, Pierre‐Simon Rohrlich, Stuart G. Tangye, H. Bobby Gaspar, Arjan C. Lankester, Alessandro Moretta, Alan B. Rickinson
I whakaputaina 2010Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Immunology
Biology
Medicine
Genetics
Immune system
Internal medicine
Gene
Disease
T cell
Antibody
Cell biology
Pathology
Signal transduction
Atopic dermatitis
Immunodeficiency
Mutation
Primary immunodeficiency
Dermatology
Antigen
Biochemistry
CD8
Virology
B cell
Cytokine
Dupilumab
In vitro
STAT3
Apoptosis
Cancer research
Cytotoxic T cell